“I am excited and honored to assume my role as CEO, particularly at such an important time in DeCurtis’ history,” said Mr. Fournier.

ORLANDO, Fla. (PRWEB)
June 23, 2020

DeCurtis Corporation, the premier provider of location and proximity enabled solutions in complex indoor environments, announced today that Derek Fournier has been appointed CEO and President. Founder and former CEO, David DeCurtis, will assume the role of Chairman of the Board, effective immediately.

“DeCurtis Corporation has been on an incredible journey for the last twenty years, and we have been fortunate to work with stellar clients on truly transformational solutions,” said David DeCurtis, Chairman of the Board at DeCurtis Corporation. “Derek has been with us since we first began focusing on cruise and indoor location services and has been a fundamental force in driving us to be the recognized leader in that space. His leadership as President for the past two years make it clear that he is the right choice to lead us into the future as we grow our presence in verticals including healthcare, education, commercial real estate and tourism.”

Mr. Fournier has been with DeCurtis Corporation for more than 10 years, and has served as President since 2018, during which he was responsible for business operations, sales and marketing functions. During his tenure as President, DeCurtis Corporation has created and gone to market with the premier architecture for location and proximity solutions serving complex indoor environments built atop the most advanced experience platform available on the market, the DeCurtis Experience Platform (DXP)™.

Under Mr. Fournier’s stewardship, DeCurtis recently launched DeCurtis Shield™, a combination of facial recognition and thermal imaging solutions to assess temperature movements of personnel. Unlike other temperature reading point-solutions in the marketplace, when tied to the DXP, DeCurtis Shield enables businesses to quickly deploy, assess, and create real-time and retroactive timelines to address potential outbreaks, identify interaction risks, as well as strategically plan for cleaning protocols.

“I am excited and honored to assume my role as CEO, particularly at such an important time in DeCurtis’ history,” said Mr. Fournier. “While the industries we serve face unique challenges, we are committed and well-equipped to utilize our industry-leading, tested and proven solutions to enable our clients and partners to open and operate their businesses safely. We have an amazing international team of compassionate and brilliant folks, and I look forward to continuing to collaborate with them to solve crucial pain-points for our clients across the many verticals in which we operate.”

About DeCurtis Corporation

DeCurtis Corporation is the premier provider of location and proximity enabled solutions in complex indoor environments with a focus on health, safety, and security, operational enhancement, and experience evolution. Creator of Mobile Assembly Suite (MAS™), the DeCurtis Experience Platform (DXP™), and DeCurtis Shield™, DeCurtis Corporation is the leader in providing transformational experience technology based on decades of deep industry knowledge in the cruise space that is applicable to other sectors. With a vast range of experience working with some of the world’s best, most-recognized brands, DeCurtis Corporation transforms the guest experience to be safer, secure and more efficient through the creative application of the latest technology. For more information on DeCurtis Corporation, please visit http://www.decurtis.com.

Press Contact:

Stephanie Casimiro, Director of Marketing

DeCurtis Corporation

Tel: (407) 965-1395

Direct: (386) 451-1194

Email: stephanie.casimiro@decurtis.com

Web: http://www.decurtis.com

Share article on social media or email:

As we collectively battle the COVID-19 pandemic, customer care is an even bigger consideration

PORTLAND, Ore. (PRWEB)
June 23, 2020

Capsa Healthcare announces it has been named the top provider in client satisfaction for computing workstations by health IT market research organization Black Book. The recognition is in-step with Capsa’s ongoing focus to provide world-class technology, tools and support for clinicians on the front lines of healthcare today.

“This is an honor to be recognized for what we do best,” says Craig Rydingsward, Capsa Healthcare’s Acute Care Vice President. “Capsa stakes its reputation on creating solutions to help our customers deliver excellence, every day. As we collectively battle the COVID-19 pandemic, that is an even bigger consideration. Now more than ever our top priority is helping clinicians safely, effectively, and efficiently care for their patients by responding to their evolving needs.”

Capsa Healthcare provides an extensive portfolio of mobile computing workstations, wall mount solutions, and medical carts for use in hospitals and other care settings. Designed to be ergonomic, lightweight and customizable, Capsa products help hospital nursing and IT professionals enhance patient care, safety, and workflow. Our highly respected product lines include the M38e, the most proven point-of-care computing cart produced; CareLink nurse workstations with onboard communications, steering assistance, and N-Sight intelligent platform for proactive cart fleet management; and SlimCart documentation carts for simple workstation needs.

Black Book Market Research is the premier provider of competitive intelligence, market research, opinion mining, sentiment analysis, services evaluation and strategic consulting services. In Black Book’s annual Clinical IT Support Products survey (conducted Q4 2019 to Q1 2020), the firm surveyed 2,448 EHR and healthcare IT professionals. Over 35% percent of major U.S. health systems and affiliated hospitals were represented in the 2020 survey. The company measures customer satisfaction across 18 electronic health records-focused performance indicators such as strategic alignment of client goals, innovation, training, ethics, breadth of offerings, integration, pricing, and cybersecurity to name a few. The survey methodology and full listing of rankings can be found at http://www.blackbookmarketresearch.com.

###

About Capsa Healthcare

Capsa Healthcare is a worldwide leader in developing and delivering innovative healthcare solutions for a wide spectrum of care providers. With 50+ years of experience, Capsa Healthcare offers a unique ability to meet the demands of diverse healthcare environments and offers a broad range of products including mobile computing solutions, medication carts, medical carts, and pharmacy automation solutions. Headquartered in Portland, OR, Capsa Healthcare has over 400 employees with management, sales, and production offices throughout the world. To learn more, visit http://www.capsahealthcare.com or call 800-437-6633.

Follow Capsa Healthcare on Facebook (https://www.facebook.com/capsahealthcare/), Twitter (https://twitter.com/CapsaHealthcare), and LinkedIn (https://www.linkedin.com/company/capsahealthcare). ###

Share article on social media or email:

InfoMart’s SymTem is the solution companies need for a safe back-to-work strategy. It’s quick, there is no equipment investment, it’s easy, and it’s compliant with all necessary regulations, including the EEOC, ADA, and CDC guidelines. — Tammy Cohen, Founder & Chief Visionary Officer, InfoMart

ATLANTA (PRWEB)
June 23, 2020

InfoMart announces SymTem, an app that enables employees and contractors to complete a daily COVID-19 symptom survey and temperature check before being issued a digital work-ready badge. Powered by InfoMart’s 30+ years of experience as a leader in global background screening and identity verification services, SymTem is the solution companies need to safely return to work.

The process is simple: the user receives a notification each day for assessment, opens the app, completes a symptom assessment, and takes their temperature. From there, the app will use an employer’s protocols to determine whether the employee/contractor can work onsite, if they should work remotely, or if they should seek additional medical assessment.

“SymTem is the solution companies need for a safe back-to-work strategy. It’s quick, there is no equipment investment, it’s easy, and it’s compliant with all necessary regulations, including the EEOC, ADA, and CDC guidelines,” said Tammy Cohen, InfoMart’s Founder & Chief Visionary Officer. “We went a step further than symptom screening–we’ve also added re-entry services and products mostly sourced from small- and diverse-owned businesses.”

Highly configurable, SymTem is the perfect solutions for a variety of uses, including onsite and remote employees, contractors, visitors, gig workers/customers, students, prospective tenants, and more.

SymTem boasts some of the best COVID-19 screening features available on the market:

• 100% contactless process
• Workflows for a variety of use cases
• Configurable QR code badges
• Custom notifications
• Trend reporting by location
• Healthcare referrals for symptomatic users

This COVID-19 assessment app is an addition to InfoMart’s New World of Work Suite, a slate of services that assist companies in screening employees, candidates, and contractors for the new normal. This suite includes re-entry screening packages, virtual drug testing, and ASAP ID, the premier solution for remote onboarding.

Learn more about the New World of Work Suite. For media inquiries, please contact Media(at)InfoMart-USA(dot)com.

About InfoMart

InfoMart has been revolutionizing the global background and identity screening industry for 30 years, providing businesses the information they need to make informed hiring decisions. They develop innovative technology that modernizes talent onboarding, including a first-to-market biometric identity authentication application and a verified sanctions search. The WBENC-certified company is a founding member of the Professional Background Screening Association, and they have achieved PBSA accreditation in recognition of their consistent business practices and commitment to compliance with the FCRA. The company is dedicated to customer service, speed, and accuracy, and it has been recognized for its success, workplace culture, and corporate citizenship with over 45 industry awards. To Get the Whole Story on InfoMart, please visit http://www.InfoMart-USA.com, follow @InfoMartUSA, or call (770) 984-2727.

Share article on social media or email:

MilliporeSigma Calling all Food Heroes to Food and Beverage Week, June 23-25, 2020

YORBA LINDA, Calif. (PRWEB)
June 23, 2020

MilliporeSigma, a leader in life science, is bringing together hundreds of food and beverage industry leaders, collaborators, scientists, and academia throughout North America.

Join the event to learn more about how MilliporeSigma’s food and beverage solutions can help you with your critical testing and innovative lab solution needs.

MilliporeSigma’s Food and Beverage week is a three-day event highlighting three renowned speakers. Kicking off the presentations, Timothy Cser, Sr. Technology Specialist at MilliporeSigma, will be speaking on “Environmental Monitoring Tools to Measure Microbiological Control in the Food Industry.” Dr. Matthias Nold, Product Manager of Reference Materials at MilliporeSigma will speak to “Reference Materials: An Introduction to quality grades and an overview on the different types for Food and Beverages,” and Justyce Jedlicka, Food & Beverage Regulatory Liaison at MilliporeSigma will finish off the presentations by touching on “2020 Food & Beverage Regulatory Trends, Impact and Next Steps.”

This virtual event will include recorded product demonstrations and live chats with technology specialists in an interactive environment, providing the ability to ask valuable questions and encounter thought-provoking discussions. Additionally, the event will include virtual booths centered around Microbiology, Chemical analysis, Lab Water, Innovation, and Thanking Food Heroes.

“We are excited to bring a one of a kind virtual event to our Food and Beverage customers at a time when trade shows have been postponed. Providing our customers the opportunity to have access to webinars, virtual booths, and specialists to answer their critical questions is crucial for them to continue the great work they are doing,” said Kelli Mazzie, BioMonitoring Field Marketing Associate at MilliporeSigma.

Produced on LabRoots’ robust platform, this interactive environment with an exhibit hall, poster hall and an Education Center, allows attendees to connect seamlessly across all desktop and mobile devices.

For more information or to register for the event, click here.

About MilliporeSigma

We at MilliporeSigma (the U.S. life science business of Merck KGaA, Darmstadt, Germany) are here to partner with you and your food safety teams enabling you to improve lab testing efficiencies with our reliable products and services that meet ever changing regulations. MilliporeSigma’s portfolio spans more than 300,000 products with 19,000 employees and 72 manufacturing sites worldwide. We understand microbiology and analytical food safety testing labs work tirelessly to provide consumers with safe and high-quality food products that require access to trusted brands like:

• Millipore® Preparation, Separation, Filtration & Monitoring products for your Hygiene, Environmental Monitoring & Pathogen detection needs
• Supelco® Analytical Products for your analytical analysis of food contamination and authenticity including certified reference materials, columns, & reflectometers
• Milli-Q® Lab Water Solutions for best-in-class laboratory water
• Sigma Aldrich® Lab & Production materials, including chemicals, inorganics & solvents

It is through our collaborations and partnerships that we can advance the safety and analysis throughout the supply chain, manufacturing and distribution of foods and beverages. Helping you produce consistent results, run efficient testing labs, maintain public trust, and keep our loved ones safe. Because we all want to trust what we eat.

About LabRoots

LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email:

The Kerafast mission is to advance scientific research by facilitating access to unique lab-made reagents, and we are working hard to get the Delta-G-VSV Pseudotyping System into the hands of scientists who are moving coronavirus research forward.

BOSTON (PRWEB)
June 23, 2020

Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment.

The Delta-G-VSV Pseudotyping System has proven useful for identifying cellular receptors for viruses, screening for entry inhibitors, and evaluating neutralizing antibody responses following vaccination. It is a reverse genetics system in which the G protein of vesicular stomatitis virus (VSV) has been deleted, allowing for the production of VSV pseudotypes with the envelope glycoproteins of heterologous viruses, including those that typically require high-level containment such as coronaviruses. Because the infectivity of the VSV pseudotypes is restricted to a single round of replication, research can be performed using just BSL-2 containment.

The Delta-G-VSV Pseudotyping System is used as a virus model system by researchers worldwide, and it is now being applied to study COVID-19 infection. Scientists can insert the SARS-CoV-2 spike protein into the modified VSV, enabling research at a lower biosafety level than required for live coronavirus. In addition, the system enables rapid screening for neutralizing antibodies, which can be useful for evaluating potential vaccines as well as determining whether people possess protective antibodies following exposure to COVID-19 infection.

“Researchers worldwide have been working at unprecedented speeds to better understand and slow the coronavirus pandemic,” said Travis Riedel, PhD, MBA, Vice President of Product Development at Kerafast. “The Kerafast mission is to advance scientific research by facilitating access to unique lab-made reagents, and we are working hard to get the Delta-G-VSV Pseudotyping System into the hands of scientists who are moving coronavirus research forward.”

“With our lab’s Delta-G-VSV Pseudotyping System, we’ve had a real opportunity to contribute to the global fight against the COVID-19 pandemic,” said Michael Whitt, PhD, associate dean and chair of the Department of Medical Education in the University of Tennessee Health Science Center and a professor in the Department of Microbiology, Immunology and Biochemistry. “Our partnership with Kerafast enables us to distribute our reagents to more scientists with less effort, accelerating the system’s adoption and use by coronavirus researchers around the world.”

Various Delta-G-VSV reagents are available via the Kerafast catalog, including pseudotyped viruses, plasmids, and an optimized cell line. They can all be ordered through a user-friendly research-use-only click license, after which a portion of the proceeds is returned to the Whitt laboratory to support future research. Under this arrangement, scientists worldwide can easily access the reagents without a time-consuming Material Transfer Agreement (MTA). The Delta-G-VSV Pseudotyping System has been available through Kerafast since 2012, and since the coronavirus pandemic began in 2020, the reagents have been shipped to researchers in 22 different countries across four continents.

For more information and a list of Delta-G-VSV Pseudotyping System reagents, please visit our website here.

More information on the Whitt laboratory can be found here.

About Kerafast

Kerafast, Inc. is reagent company whose primary mission is to make unique laboratory-made research tools easily accessible to the global scientific community. Through an online platform, Kerafast helps remove barriers to transferring bioresearch materials within the scientific community and returns generous royalty payments to the contributing investigators and their institutions. Since its founding in 2011, Kerafast has partnered with more than 190 academic research institutions internationally and provided reagents to scientists in 63 countries across six continents. In 2018, Kerafast merged with Absolute Antibody, a company specializing in recombinant antibody technology, to further improve the selection of research tools available to the scientific community. For more information, visit Kerafast.com.

Contact:

Lisa Merolla    

Director of Marketing

Kerafast Inc.

617-336-3228 x610

lisa.merolla@kerafast.com

###

Share article on social media or email: